Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2025
Reporting Period: Single event date (May 12, 2025)
This filing serves as a Regulation FD disclosure regarding an upcoming investor presentation. It does not cover a standard financial reporting period (quarter or year).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a corporate event rather than a financial statement.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The report solely announces a scheduled management presentation.
Guidance, Outlook, and Management Commentary
- Event: Chair and CEO Jasbir Seehra, Ph.D., will participate in a fireside chat at the Bank of America 2025 Global Healthcare Conference.
- Date and Time: Tuesday, May 13, 2025, at 8:00 p.m. Eastern time.
- Content: The filing incorporates a press release (Exhibit 99.1) but does not contain specific financial guidance, risk factors, or unusual items within the text of the 8-K itself.
Investor Verification Checklist
- Verify the availability and content of the press release attached as Exhibit 99.1 for details on the conference presentation.
- Confirm the live stream or replay availability for the Bank of America 2025 Global Healthcare Conference on May 13, 2025.
- Note that this filing explicitly states the information is not "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically referenced.